HK Stock Market Move | CHERVON (02285) rose over 9%, expected annual net profit not less than 110 million US dollars, turning loss into profit on a year-on-year basis.
Spring Peak Holdings (02285) rose more than 9%, as of press time, up 9.35%, reporting 18.72 Hong Kong dollars with a turnover of 82.724 million Hong Kong dollars.
CHERVON (02285) rose more than 9%, up 9.35% as of press time to 18.72 Hong Kong dollars, with a turnover of 827.24 million Hong Kong dollars.
On the news front, CHERVON announced a profit improvement, expecting a net profit of approximately $110-120 million in 2024, while in 2023 the net loss was approximately $37.2 million. The adjusted net profit (excluding non-recurring costs related to the positioning adjustment of the Steinheim base in Germany) is expected to be around $135-145 million.
According to the announcement, the expected net profit growth is mainly due to a revenue increase of about 25% to 30% from last year, benefited from the end of the channel destocking cycle. The strong performance of the company's flagship brand EGO in end sales further boosted customer orders; as a result of the recovery in scale, optimization of business structure, favorable factors such as exchange rates, and raw material costs, the gross profit margin has improved; and the continuous improvement of operational efficiency.
Related Articles

US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.

US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.

US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.

US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.

US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.

RECOMMEND